Q1 Earnings Forecast for TSE:CPH Issued By Stifel Canada

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) – Equities research analysts at Stifel Canada issued their Q1 2025 earnings per share estimates for shares of Cipher Pharmaceuticals in a report issued on Monday, March 24th. Stifel Canada analyst J. Keywood expects that the company will post earnings of $0.21 per share for the quarter. The consensus estimate for Cipher Pharmaceuticals’ current full-year earnings is $1.29 per share. Stifel Canada also issued estimates for Cipher Pharmaceuticals’ Q2 2025 earnings at $0.24 EPS, Q3 2025 earnings at $0.26 EPS, Q4 2025 earnings at $0.26 EPS and FY2025 earnings at $0.99 EPS.

Cipher Pharmaceuticals Stock Down 1.3 %

Shares of CPH opened at C$12.16 on Wednesday. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. The business has a fifty day moving average of C$12.82 and a 200 day moving average of C$14.34. The company has a market cap of C$218.31 million, a PE ratio of 13.43 and a beta of 1.20. Cipher Pharmaceuticals has a 52-week low of C$7.90 and a 52-week high of C$19.69.

Insider Activity

In other news, Director Harold Morton Wolkin sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total transaction of C$47,215.00. Insiders own 42.00% of the company’s stock.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.